Main > HEMATOLOGY > USA. G. Sickle Cell Dis.>Treat.>

---

USA. G. Sickle Cell Dis.>Treat.>'s subsections
(*) EU CE Mark Date: 2022. 02.16
(*) UK Approval Date: 2022. 07.26
(*) USA Approval Date: 2019. 11.25
(*) USA Launch Date: 2022. 01.10
>HbS Polymerization Inhibitor Tabs>
Company
Generic Name: Voxelotor
HbS: Hemoglobin S
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 28
Patent>UpDate: 2022. 01.04
RTM
RTM Web-Site

USA. G. Sickle Cell Dis.>Treat.>'s products
This section has no products